Trials / Completed
CompletedNCT04666922
A Study in Healthy Men to Test How the Body Takes up and Tolerates Different Doses of BI 765080
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Rising Intravenous Doses of BI 765080 in Healthy Male Subjects (Single-blind, Randomised, Placebo-controlled, Parallel-group Design)
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 48 (actual)
- Sponsor
- Boehringer Ingelheim · Industry
- Sex
- Male
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The main objectives of this trial are to investigate safety, tolerability, and pharmacokinetics of BI 765080 in healthy male subjects following intravenous administration of single rising doses.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BI 765080 | BI 765080 |
| DRUG | Placebo | Placebo; 0.9% saline for injection |
Timeline
- Start date
- 2021-01-14
- Primary completion
- 2021-08-25
- Completion
- 2021-08-25
- First posted
- 2020-12-14
- Last updated
- 2024-02-23
- Results posted
- 2024-02-23
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT04666922. Inclusion in this directory is not an endorsement.